- Home
- CRGO vs IMA Comparison
CRGO vs IMA Comparison
Compare CRGO & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- IMA
- Stock Information
- Founded
- CRGO 2012
- IMA 2019
- Country
- CRGO Spain
- IMA United States
- Employees
- CRGO N/A
- IMA N/A
- Industry
- CRGO Blank Checks
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRGO Finance
- IMA Health Care
- Exchange
- CRGO Nasdaq
- IMA Nasdaq
- Market Cap
- CRGO 165.6M
- IMA 159.1M
- IPO Year
- CRGO N/A
- IMA N/A
- Fundamental
- Price
- CRGO $3.18
- IMA $8.35
- Analyst Decision
- CRGO
- IMA
- Analyst Count
- CRGO 0
- IMA 0
- Target Price
- CRGO N/A
- IMA N/A
- AVG Volume (30 Days)
- CRGO 80.0K
- IMA 48.0K
- Earning Date
- CRGO 08-18-2025
- IMA 11-15-2025
- Dividend Yield
- CRGO N/A
- IMA N/A
- EPS Growth
- CRGO N/A
- IMA N/A
- EPS
- CRGO N/A
- IMA N/A
- Revenue
- CRGO $27,155,000.00
- IMA $4,300,000.00
- Revenue This Year
- CRGO $27.56
- IMA N/A
- Revenue Next Year
- CRGO $24.45
- IMA N/A
- P/E Ratio
- CRGO N/A
- IMA N/A
- Revenue Growth
- CRGO 27.02
- IMA N/A
- 52 Week Low
- CRGO $1.27
- IMA $7.95
- 52 Week High
- CRGO $4.42
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- CRGO 51.86
- IMA N/A
- Support Level
- CRGO $2.93
- IMA N/A
- Resistance Level
- CRGO $3.24
- IMA N/A
- Average True Range (ATR)
- CRGO 0.17
- IMA 0.00
- MACD
- CRGO -0.03
- IMA 0.00
- Stochastic Oscillator
- CRGO 44.35
- IMA 0.00
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.